Future of drugs-Diabetes_Ranirestat
Drug
Name
|
Ranirestat
|
Structure
|
|
Drug Code
|
AS-3201
|
Synonym
|
(3R)-2'-(4-bromo-2-fluorobenzyl)-1'H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone
|
Molecular Formula
|
C17H11BrFN3O4
|
Innovator
|
Dainippon Sumitomo Pharma
PharmaKyorin
|
Condition
|
Diabetic nephropathy (Orphan
drug status)
|
Mechanism of Action
|
Aldose reductase inhibitor
|
Clinical Phase
|
III in USA
|
Comments
Post a Comment